Multiparametric Magnetic Resonance Imaging for Prostate Cancer

Phase-Based Progress Estimates
Mayo Clinic in Rochester, Rochester, MNProstate CancerMultiparametric Magnetic Resonance Imaging - DiagnosticTest
What conditions do you have?

Study Summary

This trial looks at how well MRI works in finding and staging prostate cancer, which may help treatment planning.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: Up to 2 years

Up to 2 years
Diagnostic performance of overall prostate imaging reporting and data system (PI-RADS) score
Diagnostic performance of the individual prostate imaging reporting and data system (PI-RADS) score
Risk prediction model

Trial Safety

Trial Design

1 Treatment Group

Diagnostic (mpMRI)
1 of 1

Experimental Treatment

852 Total Participants · 1 Treatment Group

Primary Treatment: Multiparametric Magnetic Resonance Imaging · No Placebo Group · N/A

Diagnostic (mpMRI)
Experimental Group · 1 Intervention: Multiparametric Magnetic Resonance Imaging · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 2 years

Who is running the clinical trial?

ECOG-ACRIN Cancer Research GroupLead Sponsor
108 Previous Clinical Trials
172,583 Total Patients Enrolled
4 Trials studying Prostate Cancer
1,853 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,153 Previous Clinical Trials
41,161,456 Total Patients Enrolled
538 Trials studying Prostate Cancer
502,297 Patients Enrolled for Prostate Cancer
Clare Tempany-AfdhalPrincipal InvestigatorECOG-ACRIN Cancer Research Group

Eligibility Criteria

Age 18+ · Male Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is enrollment currently available for this clinical experiment?

"Per the data available on, enrollment is ongoing for this medical trial that was initially posted in July of 2018 and last updated at the end of June 2022." - Anonymous Online Contributor

Unverified Answer

How many research participants are currently included in this experiment?

"To complete this trial, 852 participants that meet the enumerated criteria need to be recruited. There are two primary sites offering participation in this study: Mayo Clinic Hospital located in Phoenix, Arizona and another location at the original Mayo Clinic facility in Rochester, Minnesota." - Anonymous Online Contributor

Unverified Answer

Is there a substantial presence of this research taking place in North America?

"This trial has 43 active sites, such as Mayo Clinic Hospital in Phoenix, Mayo Clinic Rochester and Mayo Clinic Arizona Scottsdale." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.